| Product Code: ETC12942808 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia mRNA Vaccines and Therapeutics Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Malaysia mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.7 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malaysia mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on healthcare and immunization programs |
4.2.2 Growing demand for advanced healthcare solutions |
4.2.3 Rising prevalence of infectious diseases |
4.2.4 Technological advancements in mRNA vaccine research and development |
4.3 Market Restraints |
4.3.1 Regulatory challenges and approval processes |
4.3.2 High production costs and pricing pressures |
4.3.3 Limited awareness and acceptance of mRNA vaccines in the market |
4.3.4 Potential safety concerns and vaccine hesitancy issues |
5 Malaysia mRNA Vaccines and Therapeutics Market Trends |
6 Malaysia mRNA Vaccines and Therapeutics Market, By Types |
6.1 Malaysia mRNA Vaccines and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031F |
6.1.4 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Influenza Vaccine, 2021 - 2031F |
6.1.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Rabies Vaccine, 2021 - 2031F |
6.1.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031F |
6.1.7 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By CMV Vaccine, 2021 - 2031F |
6.2 Malaysia mRNA Vaccines and Therapeutics Market, By Therapeutic Type |
6.2.1 Overview and Analysis |
6.2.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031F |
6.2.4 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.2.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031F |
6.2.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031F |
6.3 Malaysia mRNA Vaccines and Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4 Malaysia mRNA Vaccines and Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intramuscular Injection, 2021 - 2031F |
6.4.3 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Subcutaneous Injection, 2021 - 2031F |
6.4.4 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intradermal Injection, 2021 - 2031F |
6.4.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intravenous Infusion, 2021 - 2031F |
6.4.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oral Delivery, 2021 - 2031F |
6.5 Malaysia mRNA Vaccines and Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.5.6 Malaysia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Malaysia mRNA Vaccines and Therapeutics Market Import-Export Trade Statistics |
7.1 Malaysia mRNA Vaccines and Therapeutics Market Export to Major Countries |
7.2 Malaysia mRNA Vaccines and Therapeutics Market Imports from Major Countries |
8 Malaysia mRNA Vaccines and Therapeutics Market Key Performance Indicators |
8.1 Research and development investment in mRNA vaccine technologies |
8.2 Number of clinical trials and their success rates |
8.3 Adoption rate of mRNA vaccines in healthcare facilities |
8.4 Number of partnerships and collaborations in the mRNA vaccine market |
8.5 Rate of adverse events reported for mRNA vaccines |
9 Malaysia mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
9.1 Malaysia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Malaysia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.3 Malaysia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Malaysia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 Malaysia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malaysia mRNA Vaccines and Therapeutics Market - Competitive Landscape |
10.1 Malaysia mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Malaysia mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here